These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37580923)

  • 1. Preparation and evaluation of the curcumin niosomes: In vitro and in vivo.
    Li Zhu Meijuan Sun -; Longyuan Wang -; Yuefen Liu -; Haijun Qu -
    Pak J Pharm Sci; 2023 May; 36(3):755-764. PubMed ID: 37580923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization and in vivo evaluation of novel hyaluronan containing niosomes tailored by Box-Behnken design to co-encapsulate curcumin and quercetin.
    Sadeghi Ghadi Z; Dinarvand R; Asemi N; Talebpour Amiri F; Ebrahimnejad P
    Eur J Pharm Sci; 2019 Mar; 130():234-246. PubMed ID: 30711688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin entrapped hyaluronan containing niosomes: preparation, characterisation and
    Sadeghi Ghadi Z; Ebrahimnejad P
    J Microencapsul; 2019 Mar; 36(2):169-179. PubMed ID: 31104531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation Development and Evaluation of Novel Vesicular Carrier for Enhancement of Bioavailability of Poorly Soluble Drug.
    Sharma S; Bhatt S; Saini V
    Pharm Nanotechnol; 2021; 9(1):70-82. PubMed ID: 33231151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis.
    Moghddam SR; Ahad A; Aqil M; Imam SS; Sultana Y
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():789-97. PubMed ID: 27612773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.
    Obeid MA; Khadra I; Albaloushi A; Mullin M; Alyamani H; Ferro VA
    Beilstein J Nanotechnol; 2019; 10():1826-1832. PubMed ID: 31579065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
    Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
    Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
    Kamboj S; Saini V; Bala S
    ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation.
    Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
    J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded niosomes downregulate mRNA expression of pro-inflammatory markers involved in asthma: an
    Jin-Ying Wong ; Yin Ng Z; Mehta M; Shukla SD; Panneerselvam J; Madheswaran T; Gupta G; Negi P; Kumar P; Pillay V; Hsu A; Hansbro NG; Wark P; Bebawy M; Hansbro PM; Dua K; Chellappan DK
    Nanomedicine (Lond); 2020 Dec; 15(30):2955-2970. PubMed ID: 33252322
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and characterization of ofloxacin niosomes.
    Ramalingam N; Natesan G; Dhandayuthapani B; Perumal P; Balasundaram J; Natesan S
    Pak J Pharm Sci; 2013 Nov; 26(6):1089-96. PubMed ID: 24191311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
    Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
    Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine and Pentoxifylline laden tailored niosomes for the effective management of psoriasis: In-vitro optimization, Ex-vivo and animal study.
    Bhardwaj P; Tripathi P; Pandey S; Gupta R; Ramchandra Patil P
    Int J Pharm; 2022 Oct; 626():122143. PubMed ID: 36037986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
    Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
    Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and Characterization of Curcumin Niosomes: Antioxidant and Cytotoxicity Studies.
    Ghumman SA; Ijaz A; Noreen S; Aslam A; Kausar R; Irfan A; Latif S; Shazly GA; Shah PA; Rana M; Aslam A; Altaf M; Kotwica-Mojzych K; Bin Jardan YA
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
    Attia IA; El-Gizawy SA; Fouda MA; Donia AM
    AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.